Supported by
Bulgarian Kidney Foundation
Medical University of Varna
Cover and Content | |
1-8 |
Parsabiv (etelcalcetide) - an allosteric modulator of the calcium-sensing receptor in hemodialysis patients with SHPT | |
Snezhana Atanasova | 9-12 |
Assisted Peritoneial Dialysis - Opportunity For Equal Access To Renal Replacement Therapy By Peritoneal Dialysis | |
Rositsa Zortcheva, Darina Damyanova, Boryana Ivanova, Svetla Staykova | 13-16 |
Biomarkers And Quality Of Life In Patients With Chronic Kidney Disease | |
Svetla Staykova, Petar Petrov | 17-24 |
Intradialytic Hypotension – Concept, Risk Factors And Clinical Consequences | |
Snezhana Atanasova, Svetla Staykova, Dimitar Nenov | 25-31 |
Pathophysiological Mechanisms Of Renal Disorders In Patients With β-Thalassemia Major | |
Liliya Stoyanova | 32-36 |
Reduction Of Proteinuria In Patients With Diabetes Mellitus Type 2 With Empagliflozin Treatment | |
Anton Dinkov, Branimir Kanazirev | 37-39 |
The Art of Communication… | |
Miroslava Benkova-Petrova, Aleksandar Petrov, Svetla Staykova | 40-45 |